Cargando…

Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies

SIMPLE SUMMARY: Cervical cancers is a human papillomavirus infection-induced gynecologic cancer. Due to the uneven access to prevention measures in the world, it is still a leading cause of cancer death in women in low- and middle-income countries. The mainstay of treatment for early-stage cervical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yuedan, Rassy, Elie, Coutte, Alexandre, Achkar, Samir, Espenel, Sophie, Genestie, Catherine, Pautier, Patricia, Morice, Philippe, Gouy, Sébastien, Chargari, Cyrus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139662/ https://www.ncbi.nlm.nih.gov/pubmed/35626051 http://dx.doi.org/10.3390/cancers14102449

Ejemplares similares

Brachytherapy for the Conservative Treatment of Female Peri-Urethral Carcinoma
por: Andraud, Mickaël, et al.
Publicado: (2022)

Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France
por: Bentahila, Rita, et al.
Publicado: (2022)

Cervical Cancer and Fertility-Sparing Treatment
por: Zaccarini, François, et al.
Publicado: (2021)

False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology
por: Gouy, Sebastien, et al.
Publicado: (2021)

Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review
por: Bockel, Sophie, et al.
Publicado: (2021)

Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy
por: Holub, Katarzyna, et al.
Publicado: (2020)

Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients
por: Escande, Alexandre, et al.
Publicado: (2020)

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer
por: Leary, Alexandra, et al.
Publicado: (2020)

Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
por: Gouy, Sebastien, et al.
Publicado: (2017)

Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types
por: Gouy, Sebastien, et al.
Publicado: (2017)

Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy
por: Bockel, Sophie, et al.
Publicado: (2019)

Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy?
por: Escande, Alexandre, et al.
Publicado: (2016)

Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2020)

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
por: Genestie, Catherine, et al.
Publicado: (2019)

Metabolic features of cancer cells impact immunosurveillance
por: Joseph, Adrien, et al.
Publicado: (2021)

BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside
por: Boussios, Stergios, et al.
Publicado: (2022)

Can Precision Oncology Benefit Patients With Cancers of Unknown Primary?
por: Rassy, Elie, et al.
Publicado: (2023)

Venezia applicator with oblique needles improves clinical target volume coverage in distal parametrial tumor residue compared to parallel needles only
por: Kissel, Manon, et al.
Publicado: (2021)

Implementation of Image-Guided Brachytherapy for Pediatric Vaginal Cancers: Feasibility and Early Clinical Results
por: Terlizzi, Mario, et al.
Publicado: (2022)

Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients’ health quality perception
por: Bourdais, Rémi, et al.
Publicado: (2021)

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae
por: Sun, Roger, et al.
Publicado: (2018)

Immunotherapies in sarcoma: Updates and future perspectives
por: Ghosn, Marwan, et al.
Publicado: (2017)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020)

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
por: Linares, Christian A., et al.
Publicado: (2023)

Optimization of Patient Management During the COVID-19 Pandemic: Chest CT Scan and PCR as Gatekeepers of the Radiation Therapy Workflow
por: Sun, Roger, et al.
Publicado: (2020)

Management of Endometrial Cancer: French Society of Onco-Gynecology‘s Evaluation through a Delphi Survey
por: Marti, Carolin, et al.
Publicado: (2022)

Prediction of cervical cancer recurrence using textural features extracted from (18)F-FDG PET images acquired with different scanners
por: Reuzé, Sylvain, et al.
Publicado: (2017)

Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study
por: Vassiliou, Anna, et al.
Publicado: (2023)

Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
por: Moschetta, Michele, et al.
Publicado: (2020)

Adjuvant and neoadjuvant therapies in melanoma
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma
por: Chen, Xing, et al.
Publicado: (2022)

Neoadjuvant and adjuvant therapy in esophageal cancer
por: Weiss, Jennifer A., et al.
Publicado: (2023)

Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy
por: Zhang, Hang, et al.
Publicado: (2020)

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
por: Lee, So Heun, et al.
Publicado: (2023)

Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients
por: Deutsch, Eric, et al.
Publicado: (2016)

Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-Analysis
por: Des Guetz, Gaëtan, et al.
Publicado: (2021)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
por: Akateh, Clifford, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g20pd68ovnrgpt7jiihhd5987n